ENDRA Life Sciences Operating Income

ENDRA Life Sciences (NDRA) currently reports a operating income of $0 as of March 2026. That compares with $2.7M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore ENDRA Life Sciences's operating income history and peer comparisons.

ENDRA Life Sciences's operating income decreased from $2.7M to $0 — a 100.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ENDRA Life Sciences reported $0 in operating income as of March 2026. That compares with $2.7M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ENDRA Life Sciences, and consider following NDRA for alerts when major investors trade the stock.

ENDRA Life Sciences is classified in the Technology sector. On operating income, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing NDRA with unrelated industries.